1. Home
  2. FBIZ vs TNXP Comparison

FBIZ vs TNXP Comparison

Compare FBIZ & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIZ
  • TNXP
  • Stock Information
  • Founded
  • FBIZ 1909
  • TNXP 2007
  • Country
  • FBIZ United States
  • TNXP United States
  • Employees
  • FBIZ N/A
  • TNXP N/A
  • Industry
  • FBIZ Major Banks
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • FBIZ Finance
  • TNXP Health Care
  • Exchange
  • FBIZ Nasdaq
  • TNXP Nasdaq
  • Market Cap
  • FBIZ 390.3M
  • TNXP 335.6M
  • IPO Year
  • FBIZ N/A
  • TNXP N/A
  • Fundamental
  • Price
  • FBIZ $52.01
  • TNXP $26.54
  • Analyst Decision
  • FBIZ Buy
  • TNXP Buy
  • Analyst Count
  • FBIZ 3
  • TNXP 1
  • Target Price
  • FBIZ $58.67
  • TNXP $70.00
  • AVG Volume (30 Days)
  • FBIZ 29.8K
  • TNXP 1.9M
  • Earning Date
  • FBIZ 10-23-2025
  • TNXP 08-11-2025
  • Dividend Yield
  • FBIZ 2.23%
  • TNXP N/A
  • EPS Growth
  • FBIZ 22.50
  • TNXP N/A
  • EPS
  • FBIZ 5.60
  • TNXP N/A
  • Revenue
  • FBIZ $150,952,000.00
  • TNXP $9,831,000.00
  • Revenue This Year
  • FBIZ $17.98
  • TNXP $21.19
  • Revenue Next Year
  • FBIZ $8.26
  • TNXP $722.94
  • P/E Ratio
  • FBIZ $9.29
  • TNXP N/A
  • Revenue Growth
  • FBIZ 8.24
  • TNXP N/A
  • 52 Week Low
  • FBIZ $41.31
  • TNXP $6.76
  • 52 Week High
  • FBIZ $56.46
  • TNXP $130.00
  • Technical
  • Relative Strength Index (RSI)
  • FBIZ 58.70
  • TNXP 32.47
  • Support Level
  • FBIZ $50.93
  • TNXP $34.50
  • Resistance Level
  • FBIZ $52.88
  • TNXP $29.70
  • Average True Range (ATR)
  • FBIZ 1.00
  • TNXP 3.35
  • MACD
  • FBIZ 0.21
  • TNXP -1.55
  • Stochastic Oscillator
  • FBIZ 67.77
  • TNXP 4.29

About FBIZ First Business Financial Services Inc.

First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically all the business activity functioned through the region of the United States.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: